SCHEMBL6137517

SCHEMBL6137517

CC(O)CCCC=CCCCCCCCCCCCCC#N

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.44
ALDH1A1 P00352 1/20 0.44
HIF1A Q16665 4/20 0.38
EPAS1 Q99814 4/20 0.38
TRPV1 Q8NER1 1/20 0.37
TRPM8 Q7Z2W7 1/20 0.37
TSHR P16473 2/20 0.34
ABCG2 Q9UNQ0 2/20 0.33
CACNA2D1 P54289 1/20 0.33
CACNB2 Q08289 1/20 0.33
CACNA1C Q13936 1/20 0.33
PTGS1 P23219 1/20 0.33
PPARG P37231 1/20 0.33
OPRK1 P41145 1/20 0.33
CYP3A4 P08684 2/20 0.32
MEN1 O00255 1/20 0.32
FAAH O00519 1/20 0.32
TP53 P04637 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6137511 1.00 MAPT (0.44) MAPTALDH1A1HIF1AEPAS1TRPV1
SCHEMBL6137524 1.00 MAPT (0.44) MAPTALDH1A1HIF1AEPAS1TRPV1
SCHEMBL1858634 0.83 TSHR (0.42) MAPTALDH1A1TRPV1TSHRCYP3A4
SCHEMBL2566688 0.81
SCHEMBL26397516 0.81 MAPT (0.58) MAPTALDH1A1TRPV1TRPM8CYP3A4
SCHEMBL29066917 0.81 HIF1A (0.47) MAPTALDH1A1HIF1AEPAS1TRPV1
SCHEMBL2588504 0.81 HIF1A (0.47) MAPTALDH1A1HIF1AEPAS1TRPV1
SCHEMBL14604285 0.81 HIF1A (0.47) MAPTALDH1A1HIF1AEPAS1TRPV1
SCHEMBL2588505 0.81 HIF1A (0.47) MAPTALDH1A1HIF1AEPAS1TRPV1
SCHEMBL8611024 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050038259-A1 Hydroxyeicosenoic acid anaglogs TAISHO PHARMACEUTICAL CO., LTD. (JP) 2005-02-17 US disclosed
EP-1425258-A4 HYDROXYEICOSENOIC ACID ANALOGS TAISHO PHARMACEUTICAL CO LTD (JP) 2005-02-16 EP disclosed
EP-1425258-A2 HYDROXYEICOSENOIC ACID ANALOGS TAISHO PHARMACEUTICAL CO., LTD (JP) 2004-06-09 EP disclosed
WO-2003024390-A2 HYDROXYEICOSENOIC ACID ANALOGS TAISHO PHARMACEUTICAL CO., LTD. (JP) 2003-03-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050038259-A1 Hydroxyeicosenoic acid anaglogs HCAR1, HRH4, HCAR3 MAPT 4552/4885ALDH1A1 1290/4885HIF1A 2446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.